$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Biodegradable injectable particles for imaging 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/50
  • A61K-009/48
  • A61K-031/74
  • A61K-047/30
출원번호 US-0210677 (1994-03-18)
발명자 / 주소
  • Gref Ruxandra (Nancy FRX) Minamitake Yoshiharu (Brookline MA) Langer Robert S. (Newton MA)
출원인 / 주소
  • Massachusettes Institute of Technology (Cambridge MA 02)
인용정보 피인용 횟수 : 191  인용 특허 : 0

초록

Injectable nanoparticles or microparticles are provided that are not rapidly cleared from the blood stream by the macrophages of the reticuloendothelial system, and that can be modified as necessary to achieve variable release rates or to target specific cells or organs as desired. The terminal hydr

대표청구항

A microparticle or nanoparticle comprising an imaging agent and a copolymer consisting essentially of poly(alkylene glycol) and a polymer selected from the group consisting of polyanhydride, polyhydroxybutyric acid, polyorthoesters, polysiloxanes, polycaprolactone, poly(lactic acid), poly(glycolic a

이 특허를 인용한 특허 (191)

  1. Evan C. Unger, Acoustically active drug delivery systems.
  2. Sawhney, Amarpreet S.; Ransone, II, William H., Adhesive hydrogels for ophthalmic drug delivery.
  3. Griffiths, Gary L.; Hansen, Hans J.; Goldenberg, David M.; Lundberg, Bo B., Anti-CD74 immunoconjugates and methods.
  4. Griffiths, Gary L.; Hansen, Hans J.; Goldenberg, David M.; Lundberg, Bo B., Anti-CD74 immunoconjugates and methods.
  5. Griffiths, Gary L.; Hansen, Hans J.; Goldenberg, David M.; Lundberg, Bo B., Anti-CD74 immunoconjugates and methods.
  6. Byrd, John C.; Goldenberg, David M.; Hansen, Hans J., Anti-CD74 immunoconjugates and methods of use.
  7. Byrd, John C.; Goldenberg, David M.; Hansen, Hans J., Anti-CD74 immunoconjugates and methods of use.
  8. Byrd, John C.; Goldenberg, David M.; Hansen, Hans J., Anti-CD74 immunoconjugates and methods of use.
  9. Hansen, Hans J.; Goldenberg, David M.; Chang, Chien-Hsing, Anti-CD74 immunoconjugates and methods of use.
  10. Hansen, Hans J.; Goldenberg, David M.; Chang, Chien-Hsing, Anti-CD74 immunoconjugates and methods of use.
  11. Govindan, Serengulam V.; Goldenberg, David M., Anti-Trop-2 antibody-drug conjugates and uses thereof.
  12. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  13. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  14. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  15. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  16. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  17. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  18. Govindan, Serengulam V.; Gale, Jonathan B.; Holman, Nicholas J.; Goldenberg, David M., Antibody-SN-38 immunoconjugates with a CL2A linker.
  19. Goldenberg, David M.; Govindan, Serengulam V., Antibody-drug conjugates and uses thereof.
  20. Goldenberg, David M.; Govindan, Serengulam V., Antibody-drug conjugates and uses thereof.
  21. Fox, William Jason; Harold, Nathan; Garcia, Antonio; Tochterman, Andrew, Bioabsorbable stent with prohealing layer.
  22. Li,Jun; Li,Xu; Ni,Xiping; Leong,Kam W., Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from.
  23. Govindan, Serengulam V.; Goldenberg, David M., Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases.
  24. Ding, Ni; Michal, Gene; Pacetti, Stephen D., Carbon coating on an implantable device.
  25. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Combination therapy with anti-CD74 and anti-CD20 antibodies provides enhanced toxicity to B-cell diseases.
  26. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases.
  27. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases.
  28. Goldenberg, David M.; Cardillo, Thomas M., Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers.
  29. Goldenberg, David M.; Cardillo, Thomas M., Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer.
  30. Sawhney, Amarpreet S., Composite hydrogel drug delivery systems.
  31. Sawhney, Amarpreet S., Composite hydrogel drug delivery systems.
  32. Sawhney,Amarpreet S., Composite hydrogel drug delivery systems.
  33. Asmatulu, Ramazan; Misak, Heath; Yang, Shang-You; Wooley, Paul, Composite magnetic nanoparticle drug delivery system.
  34. Unger,Evan C., Composition comprising low density microspheres.
  35. Unger,Evan C., Composition comprising low density microspheres.
  36. Patton, John S.; Kuo, Mei-Chang; Harris, J. Milton; Leach, Chester; Perkins, Kimberly; Bueche, Blaine, Compositions of chemically modified insulin.
  37. Unger, Evan C.; Matsunaga, Terry; Yellowhair, David, Container with multi-phase composition for use in diagnostic and therapeutic applications.
  38. Margel, Shlomo; Galperin, Anna, Core and core-shell nanoparticles containing iodine for X-ray imaging.
  39. Chang, Chien-Hsing; Goldenberg, David M., Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells.
  40. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Crush recoverable polymer scaffolds.
  41. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Crush recoverable polymer scaffolds.
  42. Levy, Frank; Levy, Kimberley, Delivery system and method for the effective and reliable delivery of controlled amounts of a medical fluid.
  43. Chang, Chien-Hsing; Goldenberg, David M., Dock-and-lock (DNL) complexes for therapeutic and diagnostic use.
  44. Chang, Chien-Hsing; Goldenberg, David M., Dock-and-lock (DNL) complexes for therapeutic and diagnostic use.
  45. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  46. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  47. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  48. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  49. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  50. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  51. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  52. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  53. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  54. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  55. Govindan, Serengulam V.; Goldenberg, David M., Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
  56. Ilyinskii, Petr; Lipford, Grayson B.; Zepp, Charles, Dose selection of adjuvanted synthetic nanocarriers.
  57. Ilyinskii, Petr; Lipford, Grayson B.; Zepp, Charles, Dose selection of adjuvanted synthetic nanocarriers.
  58. Gale, David C.; Huang, Bin, Drug delivery after biodegradation of the stent scaffolding.
  59. Jarrett, Peter; El-Hayek, Rami; Sawhney, Amarpreet S.; Guedez, Sarah, Drug delivery systems and applications.
  60. Jarrett, Peter; Bassett, Michael; Blizzard, Charles D.; Sawhney, Amarpreet S., Drug delivery through hydrogel plugs.
  61. Sawhney, Amarpreet S.; Jarrett, Peter; Bassett, Michael; Blizzard, Charles, Drug delivery through hydrogel plugs.
  62. Govindan, Serengulam V.; Cardillo, Thomas M.; Goldenberg, David M., Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers.
  63. Unger Evan C., Gas filled microspheres as magnetic resonance imaging contrast agents.
  64. LaBarge,William J.; Kupe,Joachim; Anderson,Conrad, Gas treatment device, methods for making and using the same, and a vehicle exhaust system.
  65. Bogdanov Alexei ; Weissleder Ralph ; Brady Thomas J., Graft co-polymer adducts of platinum (II) compounds.
  66. Kotha, Sanjay; Sudarshan, Tirumalai S., Hemostatic composition.
  67. Ottoboni, Thomas B.; Tickner, E. Glenn; Short, Robert E.; Yamamoto, Ronald K., Hollow microspheres with controlled fragility for medical use.
  68. Sawhney, Amarpreet S.; Ransone, II, William H., Hydrogel polymeric compositions and methods.
  69. Sawhney, Amarpreet S.; Ransone, II, William H., Hydrogel polymeric compositions and methods.
  70. Sawhney, Amarpreet S.; Ransone, II, William H., Hydrogel polymeric compositions and methods.
  71. Belzer, Avrum; Kalechofsky, Neal, Hyperpolarization methods, systems and compositions.
  72. Zepp, Charles; Lipford, Grayson B.; Gao, Yun; Johnston, Lloyd; Fu, Fen-ni; Keegan, Mark J.; Baldwin, Sam, Immunomodulatory agent-polymeric compounds.
  73. Zepp, Charles; Lipford, Grayson B.; Gao, Yun; Johnston, Lloyd; Fu, Fen-ni; Keegan, Mark J.; Baldwin, Sam, Immunomodulatory agent-polymeric compounds.
  74. Zepp, Charles; Lipford, Grayson B.; Gao, Yun; Johnston, Lloyd; Fu, Fen-ni; Keegan, Mark J.; Baldwin, Sam, Immunomodulatory agent-polymeric compounds.
  75. Campbell, Patrick; Sawhney, Amarpreet S., Implants and biodegradable fiducial markers.
  76. Campbell, Patrick; Sawhney, Amarpreet S., Implants and biodegradable tissue markers.
  77. Ginty, Patrick; Quirk, Robin Andrew; Shakesheff, Kevin Morris, Injectable scaffold composition.
  78. Goldenberg, David M.; Hansen, Hans J.; Chang, Chien-Hsing, Isolation, detection, diagnosis and/or characterization of circulating Trop-2-positive cancer cells.
  79. Evan C. Unger ; DeKang Shen, Lipid soluble steroid prodrugs.
  80. Unger, Evan C., Low density microspheres and their use as contrast agents for computed tomography and in other applications.
  81. Davis Stanley S.,GBX ; Illum Lisbeth,GBX ; Christy Nicola,GBX ; Moghimi Moein,GBX, Lymphatic delivery methods.
  82. Woiszwillo James E. ; Brown Larry R. ; Scott Terrence L. ; Di Jie ; Sudhalter Judith ; Blizzard Charles D., Macromolecular microparticles and methods of production and use.
  83. Woiszwillo James E. ; Brown Larry R. ; Scott Terrence L. ; Di Jie ; Sudhalter Judith ; Blizzard Charles D. ; Riske Frank J., Macromolecular microparticles and methods of production and use.
  84. Woiszwillo James E. ; Brown Larry R. ; Scott Terrence L. ; Di Jie ; Sudhalter Judith ; Blizzard Charles D. ; Riske Frank J., Macromolecular microparticles and methods of production and use.
  85. Kotha,Sanjay; Sudarshan,Tirumalai S., Magnetic fluid cushioning device for a footwear or shoe.
  86. Kotha,Sanjay; Sudarshan,Tirumalai S.; Radhakrishnan,Ramachandran, Magnetic fluid power generator device and method for generating power.
  87. Huang, Songping D.; Basu, Soumitra; Khitrin, Anatoly K.; Shokouhimehr, Mohammadreza; Soehnlen, Eric Scott, Materials and methods for MRI contrast agents and drug delivery.
  88. Radhakrishnan,Ramachandran; Kotha,Sanjay; Sudarshan,Tirumalai S., Method and airbag inflation apparatus employing magnetic fluid.
  89. Metcalfe,Colin T., Method and apparatus for controlling pests.
  90. Metcalfe,Colin T., Method and apparatus for controlling pests.
  91. Sawhney Amarpreet S. ; Campbell Patrick K. ; Melanson David A., Method and apparatus for in situ formation of hydrogels.
  92. Kotha,Sanjay; Sudarshan,Tirumalai S., Method and kit for inducing hypoxia in tumors through the use of a magnetic fluid.
  93. Jarrett, Peter; El Hayek, Rami; Bassett, Michael; Biggins, James, Method for applying flowable hydrogels to a cornea.
  94. Sabaria, Patrick, Method for expansion and deployment of polymeric structures including stents.
  95. Sabaria, Patrick, Method for expansion and development of polymeric structures including stents.
  96. Straub Julie Ann ; Mathiowitz Edith ; Bernstein Howard ; Brush Henry T. ; Wing Richard E., Method for making porous microparticles by spray drying.
  97. Unger Evan C., Method of computed tomography using fluorinated gas-filled lipid microspheres as contract agents.
  98. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Method of crimping stent on catheter delivery assembly.
  99. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Method of crimping stent on catheter delivery assembly.
  100. Evan C. Unger, Method of magnetic resonance focused surgical and therapeutic ultrasound.
  101. Unger Evan C., Method of magnetic resonance focused surgical and therapeutic ultrasound.
  102. Trollsas, Mikael; Ngo, Michael H.; Anukhin, Boris; Nikanorov, Alexander; Hossainy, Syed; Papp, John E.; Jayasinghe, Dudley; Solter, Zella, Method of making a stent.
  103. Wu, Patrick P., Method of making stents with radiopaque markers.
  104. Wu, Patrick P., Method of making stents with radiopaque markers.
  105. Unger Evan C. ; Fritz Thomas A. ; Matsunaga Terry ; Ramaswami VaradaRajan ; Yellowhair David ; Wu Guanli, Method of preparing fluorinated gas microspheres.
  106. Evan C. Unger ; Thomas A. Fritz ; Terry Matsunaga ; VaradaRajan Ramaswami ; David Yellowhair ; Guanli Wu, Method of preparing gas and gaseous precursor-filled microspheres.
  107. Wu, Patrick P., Method of removing stent islands from a stent.
  108. Sawhney Amarpreet S., Methods and apparatus for in situ formation of hydrogels.
  109. Sawhney, Amarpreet S., Methods and apparatus for in situ formation of hydrogels.
  110. Stein, Adam L.; White, Jacob M., Methods and apparatuses for detecting analytes in biological fluid of an animal.
  111. Jacob Jules S. ; Mathiowitz Edith, Methods and compositions for enhancing the bioadhesive properties of polymers.
  112. Jules S. Jacob ; Edith Mathiowitz, Methods and compositions for enhancing the bioadhesive properties of polymers.
  113. Guo, Peng; Marin, Charles R.; Zhao, Yaping; Zare, Richard N., Methods and systems of making nanostructures.
  114. Unger, Evan C.; McCreery, Thomas, Methods for delivering compounds into a cell.
  115. Unger, Evan C.; McCreery, Thomas, Methods for delivering compounds into a cell.
  116. Unger, Evan C.; McCreery, Thomas, Methods for delivering compounds into a cell.
  117. Unger, Evan C., Methods for diagnostic imaging involving the use of a contrast agent and a coronary vasodilator.
  118. Unger Evan C., Methods for diagnostic imaging using a contrast agent and a renal vasodilator.
  119. Unger Evan C. ; Fritz Thomas A. ; Gertz Edward W., Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same.
  120. Zare, Richard N.; Ge, Jun, Methods of electric field induced delivery of compounds, compositions used in delivery, and systems of delivery.
  121. Chan Eric K. ; Barton Jennifer K. ; Welch Ashley J., Methods of enhanced light transmission through turbid biological media.
  122. Unger,Evan C.; Wu,Yunqiu, Methods of imaging and treatment.
  123. Unger, Evan C.; Wu, Yunqiu, Methods of imaging and treatment with targeted compositions.
  124. Unger, Evan C., Methods of ultrasound treatment using gas or gaseous precursor-filled compositions.
  125. Bernstein Howard ; Straub Julie Ann ; Brush Henry T. ; Wing Richard E., Microencapsulated fluorinated gases for use as imaging agents.
  126. Sudarshan, Tirumalai S.; Kotha, Sanjay; Radhakrishnan, Ramachandran, Multifunctional particulate material, fluid, and composition.
  127. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases.
  128. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases.
  129. Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A., Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases.
  130. Ottoboni, Thomas B.; Short, Robert E.; Gabe, Jeffrey D., Nanobubbles useful as an ultrasonic contrast agent for the lymphatic system.
  131. Peng,Xiaogang; Chen,Haiyan; Guo,Wenzhou; Wang,Y. Andrew, Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical, and thermal stability, and methods of making the same.
  132. Domb Abraham J.,ILX ; Gref Ruxandra,FRX ; Minamitake Yoshiharu,JPX ; Peracchia Maria Teresa,ITX ; Langer Robert S., Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers.
  133. Bloom, Corey Jay; Crew, Marshall David; Smithey, Daniel Tod; Miller, Warren Kenyon; Morgen, Michael Mark, Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer.
  134. Miller, Warren Kenyon; Morgen, Michael Mark; Smithey, Daniel Tod, Nanoparticles comprising a drug, ethylcellulose, and a bile salt.
  135. Bloom, Corey Jay; Crew, Marshall David; Miller, Warren Kenyon; Morgen, Michael Mark; Smithey, Daniel Tod, Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer.
  136. Bloom, Corey J.; Crew, Marshall David; Miller, Warren Kenyon, Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer.
  137. Miller, Warren Kenyon, Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate.
  138. Buzatu, Dan A.; Wilkes, Jon G.; Miller, Dwight; Darsey, Jerry A.; Heinze, Tom; Biris, Alex; Berger, Richard; Diggs, Mark, Nanotubes for cancer therapy and diagnostics.
  139. Unger, Evan C., Non-invasive methods for surgery in the vasculature.
  140. Esenaliev, Rinat O.; Prough, Donald S., Noninvasive blood analysis by optical probing of the veins under the tongue.
  141. Esenaliev,Rinat O.; Prough,Donald S., Noninvasive blood analysis by optical probing of the veins under the tongue.
  142. Unger Evan C. ; Wu Yunqiu, Optoacoustic contrast agents and methods for their use.
  143. Unger, Evan C.; McCreery, Thomas; Wu, Yunqiu, Oxygen delivery agents and uses for the same.
  144. Unger,Evan C.; McCreery,Thomas; Wu,Yunqiu, Oxygen delivery agents and uses for the same.
  145. Campbell, Patrick; Sawhney, Amarpreet S., Particulate implants and biodegradable fiducial markers.
  146. Missling, Jeff, Pharmaceutical composition and use.
  147. Miller, Warren Kenyon; Smithey, Daniel; Frankamp, Benjamin Lee; Tadday, Ralph, Pharmaceutical compositions comprising nanoparticles and a resuspending material.
  148. Varshney, Sunil K.; Hnojewyi, Olexander; Zhang, Jianxin; Rivelli, Patrick, Polyanhydride polymers and their uses in biomedical devices.
  149. Coombes Allan Gerald Arthur,GBX ; Davis Stanley Stewart,GBX ; Schacht Etienne Honore,BEX, Polymer microspheres and a method of production thereof.
  150. Anukhin, Boris; Ngo, Michael H.; Trollsas, Mikael; Hossainy, Syed; Papp, John, Polymer scaffolds having a low crossing profile.
  151. Bernstein Howard ; Straub Julie Ann ; Brush Henry T. ; Church Charles C., Polymer-lipid microencapsulated gases for use as imaging agents.
  152. Hui, Poh K.; Bishop, John E.; Madrigal, Jr., Eleodoro S., Preparation of a lipid blend and a phospholipid suspension containing the lipid blend.
  153. Hui, Poh K.; Bishop, John E.; Madrigal, Jr., Eleodoro S., Preparation of a lipid blend and a phospholipid suspension containing the lipid blend.
  154. Hui, Poh K.; Bishop, John E.; Madrigal, Jr., Eleodoro S., Preparation of a lipid blend and a phospholipid suspension containing the lipid blend.
  155. Hui, Poh K.; Bishop, John E.; Madrigal, Jr., Eleodoro S., Preparation of a lipid blend and a phospholipid suspension containing the lipid blend.
  156. Biggs, Danielle; Nettles, Heather, Process for preparing microparticles having a low residual solvent volume.
  157. Patton, John S.; Kuo, Mei-Chang; Harris, J. Milton; Leach, Chester; Perkins, Kimberly; Bueche, Blaine, Pulmonary administration of chemically modified insulin.
  158. Esenaliev Rinat O., Radiation and nanoparticles for enhancement of drug delivery in solid tumors.
  159. Pathak, Chandrashekhar P.; Thigle, Sanjay M., Radio-opaque compounds, compositions containing same and methods of their synthesis and use.
  160. Pathak, Chandrashekhar P.; Thigle, Sanjay M., Radio-opaque compounds, compositions containing same and methods of their synthesis and use.
  161. Campbell, Patrick; Sawhney, Amarpreet S., Radioopaque covalently crosslinked hydrogel particle implants.
  162. Antonio Moroni, Radiopaque compositions for visualization of medical devices.
  163. Shalaby, Shalaby W.; Gray, Kenneth David, Radiopaque iodinated and iodide-containing crystalline absorbable aliphatic polymeric materials and applications thereof.
  164. Ottoboni, Thomas B.; Short, Robert E., Reconstitutable microsphere compositions useful as ultrasonic contrast agents.
  165. Pacetti, Stephen; Bei, Joan; Wang, Karen; Liu, Annie, Scaffolds having radiopaque markers.
  166. Evan C. Unger ; Dekang Shen ; Guanli Wu, Silicon amphiphilic compounds and the use thereof.
  167. Campbell, Patrick Kenneth; Driscoll, Arthur J.; Guest, Tom, Spray for fluent materials.
  168. Campbell, Patrick Kenneth; Driscoll, Arthur J.; Guest, Tom, Spray for fluent materials.
  169. Campbell, Patrick Kenneth; Driscoll, Arthur J; Guest, Thomas, Spray for fluent materials.
  170. Jordan, Andreas, Stent for keeping open tubular structures.
  171. Wu, Patrick P., Stent with radiopaque markers.
  172. Dugan, Stephen R.; Abbate, Anthony J., Stents with radiopaque markers.
  173. Dugan, Stephen R.; Abbate, Anthony J., Stents with radiopaque markers.
  174. Wu, Patrick P., Stents with radiopaque markers.
  175. Wu, Patrick P., Stents with radiopaque markers.
  176. Goldenberg, David M.; Cardillo, Thomas M., Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors.
  177. Peng,Xiaogang; Chen,Haiyan, Synthesis of stable colloidal nanocrystals using organic dendrons.
  178. Lumauig, Rommel, System and method for attaching a radiopaque marker bead to an endoprosthesis.
  179. Unger,Evan C.; Matsunaga,Terry O.; Schumann,Patricia A., Targeted compositions for diagnostic and therapeutic use.
  180. Unger Evan C. ; Fritz Thomas A. ; Matsunaga Terry ; Ramaswami VaradaRajan ; Yellowhair David ; Wu Guanli, Targeted gas and gaseous precursor-filled liposomes.
  181. Evan C. Unger ; Thomas A. Fritz ; Terry Matsunaga ; VaradaRajan Ramaswami ; David Yellowhair ; Guanli Wu, Therapeutic delivery systems.
  182. Unger,Evan C.; Fritz,Thomas A.; Matsunaga,Terry; Ramaswami,VaradaRajan; Yellowhair,David; Wu,Guanli, Therapeutic delivery systems.
  183. Chang, Chien-Hsing; Goldenberg, David M.; Hansen, Hans J.; Rossi, Edmund A., Therapeutic use of anti-CD22 antibodies for inducing trogocytosis.
  184. Chang, Chien-Hsing; Goldenberg, David M.; Hansen, Hans J.; Rossi, Edmund A., Therapeutic use of anti-CD22 antibodies for inducing trogocytosis.
  185. Chang, Chien-Hsing; Goldenberg, David M.; Hansen, Hans J.; Rossi, Edmund A., Therapeutic use of anti-CD22 antibodies for inducing trogocytosis.
  186. Chang, Chien-Hsing; Goldenberg, David M.; Hansen, Hans J.; Rossi, Edmund A., Therapeutic use of anti-CD22 antibodies for inducing trogocytosis.
  187. Unger, Evan C., Thermal preactivation of gaseous precursor filled compositions.
  188. Missling, Jeff, Treatment of back pain by injection of microparticles of dexamethasone acetate and a polymer.
  189. Walovitch, Richard; Bernstein, Howard; Chickering, Donald; Straub, Julie, Ultrasound contrast agent dosage formulation.
  190. Walovitch, Richard; Bernstein, Howard; Chickering, III, Donald; Straub, Julie, Ultrasound contrast agent dosage formulation.
  191. Unger,Evan C., Ultrasound imaging and treatment.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로